Newsletter Subject

Paxlovid May Lower Long COVID Risk, VA Study Suggests

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Thu, Mar 23, 2023 10:52 PM

Email Preheader Text

Daily Headlines Thursday, March 23, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT

[MEDPAGE TODAY]( Daily Headlines Thursday, March 23, 2023 Today's Top Stories for {NAME} [INFECTIOUS DISEASE]( [Paxlovid May Lower Long COVID Risk, VA Study Suggests]( [ALLERGY & IMMUNOLOGY]( [Digital Inhalers May Improve Uncontrolled Asthma Management]( [ONCOLOGY/HEMATOLOGY]( [Another Win for Zolbetuximab in Advanced Gastric/GEJ Cancer]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Advancing Post-Transplant CMV Care: Resistant and Refractory CMV Management]( [NEUROLOGY]( [Autism Prevalence Is Up, CDC Report Shows]( [ORTHOPEDICS]( [FDA: Watch for Joint Replacement Device Failure After Exactech Recall]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [INFECTIOUS DISEASE]( [FDA Approves Long-Acting Antifungal for Treating Candida]( CME SPOTLIGHT [Evidence-Based Management of Adverse Effects of Immunotherapy in Relapsed/Refractory Multiple Myeloma]( [ONCOLOGY/HEMATOLOGY]( ['Cancer Alley' Lawsuit; Brown Fat and Survival; Moral Distress in Radiology]( [OPINION]( [A Conservative Blueprint for Universal Healthcare]( [MEETING COVERAGE]( [Switch to IL-23 Blocker Yields Deep Responses in Recalcitrant Plaque Psoriasis]( CME SPOTLIGHT [Improving Awareness and Evidence-Based Diagnosis of PNH]( [SPECIAL REPORTS]( [Doctor Wins $14M Judgment; Poppy Seeds and Positive Drug Tests; Fixing Nurse Wages?]( [MEETING COVERAGE]( [Biomarkers of Response With Enfortumab Vedotin in Advanced Urothelial Cancer]( [MEETING COVERAGE]( [At-Home Topical Therapy for Molluscum Contagiosum Gets High Marks]( CME SPOTLIGHT [Navigating PNH Recognition, Diagnosis, and Treatment]( [INFECTIOUS DISEASE]( [Senators Press Moderna's CEO to Drop COVID Vaccine Price]( [PUBLIC HEALTH & POLICY]( [Senators Press HHS Chief on Alzheimer's Drugs, Opioids at Budget Hearing]( [SPECIAL REPORTS]( [Despite Abortion Restrictions, Ob/Gyn Remains Competitive Residency]( CME SPOTLIGHT [Evidence-Based Strategies for Monitoring and Mitigating Adverse Events of Therapies for Relapsed/Refractory Multiple Myeloma]( [ASCO READING ROOM]( [Deborah Kaye, MD, on the Cost of First-Line Tx for Metastatic Castrate-resistant Prostate Cancer]( [NEUROLOGY]( [FDA Panel Supports Tofersen for Rare Genetic ALS]( CME SPOTLIGHT [Clinical Evidence for Current and Emerging Therapies in Relapsed/Refractory Multiple Myeloma]( # Weekly Survey [Give Paxlovid Full Approval?]( A panel of outside experts [recommended]( that the FDA grant full approval to nirmatrelvir-ritonavir (Paxlovid) for treating high-risk COVID[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-03-23&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

26/06/2024

Sent On

26/06/2024

Sent On

26/06/2024

Sent On

25/06/2024

Sent On

25/06/2024

Sent On

24/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.